Work

Egfl6 promotes ovarian cancer progression by inducing the immunosuppressive functions of tumor-infiltrating myeloid cells.

Year: 2022

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.208.supp.178.02

Authors: Sandra Cascio, Sarah Sinno, Shoumei Bai, Claudia Coronnello, Anda Vlad, Ronald J Buckanovich

Institutions: University of Pittsburgh, Magee-Womens Research Institute, Ri.MED

Language: English

Topic: Immune cells in cancer

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4313405883

Cites:

Cited by:

Related to: 10